Leiden-based RespiQ, a pioneering Dutch healthtech company, secured a €4 million grant from the European Innovation Council (EIC). This substantial funding propels respiQ’s mission to enhance the well-being of COPD patients with their groundbreaking breath diagnostics technology. The grant is part of the EIC Pathfinder Challenge: “Towards the healthcare continuum”, which is designed to support…
This content is for members only. Visit the site and log in/register to read.
The post Dutch healthtech RespiQ secures €4 million to accelerate breath diagnostics technology appeared first on EU-Startups.